Project Grant R34MH140993
- Federal Grant Award Summary The University of Southern California received a $817,597 Project Grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), awarded September 19, 2025, with completion targeted for July 31, 2030. This research project delivers a comprehensive, multimethod study designed to develop machine learning prediction models for identifying autistic children and youth at greatest risk for persistent adverse mental...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded $990,550 to Boston Children's Hospital under the Mental Health Research Grants program (CFDA 93.242) on March 10, 2026, for a research project titled "Developing Cognitive Control and Metacognition to Reduce the Functional Impact of Restricted and Repetitive Behaviors in Autism." This R61/R33 phased project grant will develop and test computer-based cognitive control training combined with...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded a $1.92 million Project Grant to the University of California, Los Angeles (UCLA) under the Mental Health Research Grants program (CFDA 93.242) on September 18, 2025, with completion targeted for August 31, 2030. The Coaching and Leadership in Autism Support Settings (CLASS) study will conduct a cluster-randomized, hybrid effectiveness-implementation trial to test the clinical effectiveness of the Research Units...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded The Regents of the University of California, San Francisco a Project Grant of $458,177 under the Mental Health Research Grants program (CFDA 93.242) for the period June 9, 2025 through June 8, 2027. The research project, titled "Leveraging Population Level Data to Inform Prevention and Treatment of Adolescent Depression Following Social Adversities," addresses the significant gap between current...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded $863,276 to the University of California, San Francisco on February 3, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct a randomized controlled trial examining the effectiveness of the Resilience in Action (RIA) curriculum for young adults with autism spectrum disorder (YAASD). The research project, which extends through November 30, 2030, will expand testing of the RIA...
- Federal Project Grant Award Summary The National Institute of Mental Health awarded a $383,832 project grant to the University of California, Davis on September 10, 2025, under the Mental Health Research Grants program (CFDA 93.242) to conduct a four-year research initiative examining caregiver engagement in early autism interventions. The project delivers a mobile health-based social support enhancement program called Family/Friend Network Support for Early Intervention (FANS-EI), designed to...
- Federal Grant Award Summary The University of Pittsburgh received a $792,006 Project Grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), awarded September 1, 2025, with completion targeted for June 30, 2030. This research initiative addresses suicidality in autistic adults through a longitudinal study enrolling 250 participants (ages 18-40), with at least half representing high-risk individuals with active suicidal ideation...
- This federal Project Grant award of $509,310.95 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) supports a research study to investigate longitudinal trajectories and social mechanisms of depression in adolescent girls with autism spectrum disorder (ASD). The study aims to (1) map depression symptom trajectories in girls with ASD and typical development from ages 10-13, (2) profile daily social experiences relevant to negative...
- Federal Project Grant Award Summary Miresource, Inc. received a $627,600 project grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), awarded on September 12, 2025, with completion targeted for March 14, 2026. The project, conducted in partnership with the nonprofit Child Mind Institute (CMI), delivers an integrated digital mental health monitoring platform designed to improve longitudinal patient tracking and enable...
- Federal Project Grant Award Summary The National Institute of Mental Health (NIMH) awarded the Research Institute at Nationwide Children's Hospital a $392,500 project grant under the Mental Health Research Grants program (CFDA 93.242) to conduct research characterizing the role of sleep brain dynamics in the emergence of depression in adolescents. The project, spanning from May 1, 2025, to April 30, 2027, will investigate biological markers of depression onset in high-risk adolescent...
Children's Hospital Los Angeles received a $769,500 Project Grant from the National Institute of Mental Health under the Mental Health Research Grants program (CFDA 93.242) awarded on March 15, 2026, with a completion date of March 14, 2029. The grant supports the development and evaluation of Cognitive Behavioral Therapy for Depression in Autistic Youth (CBT-DAY), an autism-adapted evidence-based treatment intervention designed to address the substantial gap in mental health services for autistic youth experiencing depression. The primary deliverables include conducting a randomized controlled trial to assess the feasibility, acceptability, and preliminary effectiveness of CBT-DAY when delivered by clinicians with limited autism training, as well as developing and refining an associated clinician training model. The research targets verbally fluent autistic youth (ages 11-18 with verbal IQ ≥70) and focuses on treating depressive symptoms by addressing emotional reactivity, negative self-esteem, and autism self-knowledge. This project addresses a critical clinical need, as autistic youth experience significantly higher rates of depression and suicidal ideation than non-autistic peers, yet receive inadequate treatment due to clinician shortages and limited autism-focused training. By establishing the effectiveness of an autism-adapted CBT approach in a rigorous trial setting, the research aims to reduce treatment barriers and provide clinicians with evidence-based tools to better serve this vulnerable population, ultimately improving short- and long-term health outcomes and quality of life for autistic youth with depression.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $769.5k | 3/13/26 |